Cidel Asset Management’s AstraZeneca AZN Stock Holding History

Cidel Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$44.5M	Sell	234,663 -44,827	-16%	-$8.43M	2.14%	9
2026 Q1	$55.1M	Sell	279,490 -1,726	-0.6%	-$333K	3.01%	3
2025 Q4	$51.7M	Sell	281,216 -17,939	-6%	-$3.15M	3.66%	2
2025 Q3	$45.9M	Sell	299,155 -844	-0.3%	-$128K	2.64%	7
2025 Q2	$41.9M	Buy	299,999 +14,146	+5%	+$1.98M	2.52%	9
2025 Q1	$42M	Buy	285,853 +23,017	+9%	+$3.33M	2.75%	7
2024 Q4	$34.4M	Sell	262,836 -67,587	-20%	-$9.46M	2.32%	12
2024 Q3	$51.5M	Buy	330,423 +209	+0.1%	+$33.7K	3.63%	4
2024 Q2	$51.5M	Buy	330,214 +4,653	+1%	+$700K	3.98%	3
2024 Q1	$44.1M	Buy	325,561 +45,931	+16%	+$6.08M	3.35%	5
2023 Q4	$37.7M	Buy	279,630 +2,821	+1%	+$367K	1.61%	20
2023 Q3	$37.5M	Buy	276,809 +382	+0.1%	+$52.2K	1.87%	21
2023 Q2	$39.6M	Sell	276,427 -1,311	-0.5%	-$193K	1.79%	18
2023 Q1	$38.6M	Sell	277,738 -5,718	-2%	-$769K	1.77%	17
2022 Q4	$38.4M	Sell	283,456 -1,900	-0.7%	-$238K	1.8%	14
2022 Q3	$31.3M	Sell	285,356 -9,905	-3%	-$1.26M	1.49%	23
2022 Q2	$39M	Buy	295,261 +19,671	+7%	+$2.58M	1.67%	17
2022 Q1	$36.6M	Sell	275,590 -19,237	-7%	-$2.31M	1.34%	25
2021 Q4	$34.3M	Sell	294,827 -24,700	-8%	-$2.91M	1.28%	25
2021 Q3	$38.4M	Sell	319,527 -18,575	-5%	-$2.16M	1.56%	21
2021 Q2	$40.5M	Buy	338,102 +6,951	+2%	+$763K	1.64%	20
2021 Q1	$32.9M	Buy	331,151 +158,036	+91%	+$15.9M	1.49%	22
2020 Q4	$17.3M	Sell	173,115 -92,757	-35%	-$9.82M	0.97%	34
2020 Q3	$29.2M	Buy	265,872 +1,463	+0.6%	+$163K	1.66%	21
2020 Q2	$28M	Sell	264,409 -110,115	-29%	-$11.4M	1.27%	28
2020 Q1	$33.5M	Sell	374,524 -8,139	-2%	-$766K	1.7%	22
2019 Q4	$38.2M	Sell	382,663 -4,597	-1%	-$433K	1.58%	23
2019 Q3	$34.5M	Buy	387,260 +1,061	+0.3%	+$92K	1.67%	20
2019 Q2	$31.9M	Buy	386,199 +13,903	+4%	+$1.09M	1.62%	20
2019 Q1	$30.1M	Buy	372,296 +19,880	+6%	+$1.57M	1.64%	19
2018 Q4	$26.8M	Buy	352,416 +51,281	+17%	+$4M	1.71%	19
2018 Q3	$23.9M	Sell	301,135 -35,541	-11%	-$2.69M	1.05%	31
2018 Q2	$23.6M	Buy	+336,676	New	+$24.2M	1.05%	30

Other funds holding AZN

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ZIC

ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

SAM

Sycomore Asset Management Paris, France $932M AUM 51.25% 1-Year Est. Return

PAS

Professional Advisory Services Vero Beach, Florida $836M AUM 25.79% 1-Year Est. Return

MIM

Martin Investment Management Palm Beach Gardens, Florida $300M AUM 6.05% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

Cidel Asset Management's AZN Position: Q2 2026 in Review

Cidel Asset Management reduced its AstraZeneca (AZN) stake by 16% in Q2 2026, selling an estimated $8.43M and leaving 234,663 shares worth $44.5M. The position accounts for 2.14% of the portfolio, ranked #9.

Cidel Asset Management first reported a position in AZN in Q2 2018 and has held it in 33 quarters since. The position peaked at $55.1M in Q1 2026. 233 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Cidel Asset Management held 234,663 shares of AstraZeneca worth $44.5M as of Q2 2026.
Cidel Asset Management sold 44,827 AstraZeneca shares in Q2 2026, an estimated $8.43M.
AstraZeneca made up 2.14% of Cidel Asset Management's portfolio in Q2 2026, its #9 holding.
Cidel Asset Management first reported a position in AstraZeneca in Q2 2018 and has held it in 33 quarters since.
Cidel Asset Management's AstraZeneca position peaked at $55.1M in Q1 2026.
233 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Cidel Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.